|Min. Order:||1 Gram|
|Delivery Time:||20 Days|
Model No.: 913611-97-9
Packaging: AS REQUIRED
Place of Origin: CHINA
Supply Ability: COMMERCIAL PRODUCTION
Brexpiprazole CAS number 913611-97-9,which is an experimental serotonin-dopamine activity modulator (SDAM) that acts on dopamine D2 and 5-HT2A receptors. In Dopamine D2 receptors, D2 receptor partial agonists on the mesolimbic pathway can produce functional antagonism, can effectively improve the schizophrenia due to excessive activity of D2 caused by positive symptoms; the middle cerebral cortex pathway can produce function Sexual excitement, can improve the negative symptoms caused by D2 dysfunction, cognitive impairment. Therefore, Brexpiprazole CAS number 913611-97-9 has both anti-schizophrenia and antidepressant effects. More than 1,200 patients participated in 2 Phase III clinical trials of Brexpiprazole in schizophrenia. After 6 weeks of treatment, the scores of positive and negative symptoms scales significantly increased. In the adjuvant treatment of major depressive disorder, Brexpiprazole also outperformed the placebo in phase II clinical phase III trials.
We are offering in wide range of Pharmaceutical Intermediates CAS 913611-97-9,Brexpiprazole (OPC 34712;OPC34712;OPC-34712). These high quality products are formulated by adopting quality methods and using well-tested ingredients that are procured from the certified vendors of the market. We offer these products in proper packaging of diverse quantity to meet assorted requirements of the clients.
Specifications:Available on request
Packing:Export worthy packing
Material Safety Data Sheet:Available on request
Usage: Brexpiprazole is a novel D2 dopamine partial agonist called serotonin-dopamine activity modulator approved for the treatment of schizophrenia, and as an adjunctive treatment for depression